IS6581A - Samsetning sem eykur hreyfanleika - Google Patents

Samsetning sem eykur hreyfanleika

Info

Publication number: IS6581A
Authority: IS; Iceland
Prior art keywords: combination; increases mobility; haematopoietic; mobility; increases
Prior art date: 2000-04-18

Application number

IS6581A

Other languages

English (en)

Other versions

IS2171B (is

Inventor

Ferro Laura

Porta Roberto

Iacobelli Massimo

Massimo Gianni Alessandro

Carlo Stella Carmelo

Original Assignee

Gentium Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-04-18

Filing date

2002-10-14

Publication date

2002-10-14

2002-10-14 Application filed by Gentium Spa filed Critical Gentium Spa

2002-10-14 Publication of IS6581A publication Critical patent/IS6581A/is

2006-11-15 Publication of IS2171B publication Critical patent/IS2171B/is

Links

230000003394 haemopoietic effect Effects 0.000 abstract 2
210000000130 stem cell Anatomy 0.000 abstract 2
102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 abstract 1
108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 abstract 1
241000124008 Mammalia Species 0.000 abstract 1
JNWFIPVDEINBAI-UHFFFAOYSA-N [5-hydroxy-4-[4-(1-methylindol-5-yl)-5-oxo-1H-1,2,4-triazol-3-yl]-2-propan-2-ylphenyl] dihydrogen phosphate Chemical compound C1=C(OP(O)(O)=O)C(C(C)C)=CC(C=2N(C(=O)NN=2)C=2C=C3C=CN(C)C3=CC=2)=C1O JNWFIPVDEINBAI-UHFFFAOYSA-N 0.000 abstract 1
229960004120 defibrotide Drugs 0.000 abstract 1
210000005259 peripheral blood Anatomy 0.000 abstract 1
239000011886 peripheral blood Substances 0.000 abstract 1
230000002123 temporal effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Hematology (AREA)
Diabetes (AREA)
Molecular Biology (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Peptides Or Proteins (AREA)

IS6581A 2000-04-18 2002-10-14 Samsetning sem eykur hreyfanleika IS2171B (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP00830293A EP1147777A1 (en)	2000-04-18	2000-04-18	Combination of defibrotide and G-CSF and its use to activate haematopoietic progenitors
PCT/EP2001/004105 WO2001078761A2 (en)	2000-04-18	2001-04-10	Mixture of defibrotide and g-csf ant its use for activating haematopoietic progenitors

Publications (2)

Publication Number	Publication Date
IS6581A true IS6581A (is)	2002-10-14
IS2171B IS2171B (is)	2006-11-15

Family

ID=8175292

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS6581A IS2171B (is)	2000-04-18	2002-10-14	Samsetning sem eykur hreyfanleika

Country Status (31)

Country	Link
US (1)	US20040131588A1 (is)
EP (3)	EP1147777A1 (is)
JP (1)	JP5205668B2 (is)
KR (1)	KR100849491B1 (is)
CN (1)	CN1183962C (is)
AT (2)	ATE310532T1 (is)
AU (2)	AU5832201A (is)
BG (1)	BG107203A (is)
CA (1)	CA2406179C (is)
CY (1)	CY1104971T1 (is)
CZ (1)	CZ20023426A3 (is)
DE (2)	DE60115222T2 (is)
DK (2)	DK1621207T3 (is)
EE (1)	EE200200596A (is)
ES (2)	ES2335776T3 (is)
HR (1)	HRP20020835A2 (is)
HU (1)	HUP0300560A3 (is)
IL (1)	IL152328A (is)
IS (1)	IS2171B (is)
MX (1)	MXPA02010346A (is)
NO (1)	NO20024988L (is)
NZ (1)	NZ522016A (is)
PL (1)	PL358100A1 (is)
PT (1)	PT1621207E (is)
RO (1)	RO121006B1 (is)
RU (1)	RU2248216C2 (is)
SI (1)	SI21079B (is)
SK (1)	SK14892002A3 (is)
UA (1)	UA73566C2 (is)
WO (1)	WO2001078761A2 (is)
ZA (1)	ZA200208413B (is)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8771663B2 (en)	2000-04-18	2014-07-08	Gentium Spa	Formulation having mobilising activity
WO2005014023A1 (en) *	2003-07-29	2005-02-17	Dompe' Pha.R.Ma S.P.A.	Pharmaceutical combination of g-csf and plgf useful for blood stem cell
WO2005017161A2 (en)	2003-08-13	2005-02-24	Children's Hospital Medical Center	Chimeric peptides for the regulation of gtpases
WO2005017160A2 (en) *	2003-08-13	2005-02-24	Children's Hospital Medical Center	Mobilization of hematopoietic cells
EP2103689A1 (en) *	2008-03-19	2009-09-23	Gentium S.p.A.	Synthetic phosphodiester oligonucleotides and therapeutical uses thereof
RU2376985C1 (ru) *	2008-07-17	2009-12-27	Владислав Николаевич Ласкавый	Средство для активации стволовых клеток
EP2637672B1 (en)	2010-11-12	2018-08-22	Gentium S.r.l.	Defibrotide for use in prophylaxis and/or treatment of graft versus host disease (gvhd).
ES2660969T5 (es)	2012-06-22	2021-09-03	Gentium S R L	Método basado en euglobulina para determinar la actividad biológica de defibrotida
EP3026122A1 (en)	2014-11-27	2016-06-01	Gentium S.p.A.	Cellular-based method for determining the potency of defibrotide
CN106567694A (zh) *	2016-11-14	2017-04-19	北京国泰通源技术有限公司	智能控水短节
EP3574103A4 (en) *	2018-01-12	2020-09-23	Cellmig Biolabs Inc.	METHODS OF GENERATION OF CYTOCAPSULES AND CYTOCAPSULAR TUBES
WO2021095881A1 (ja)	2019-11-13	2021-05-20	富士フイルム株式会社	加飾フィルム、成型物、及び電子デバイス
CN117072108A (zh) *	2023-06-28	2023-11-17	中国石油天然气集团有限公司	一种旋转防喷控压一体化装置、密封方法及控压方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3899481A (en)	1970-11-03	1975-08-12	Crinos Industria Farmaco	Process for the controlled partial degradation of deoxyribonucleic acid extracted from animal organs
IT1043823B (it) *	1970-11-03	1980-02-29	Prephar	Procedimento per l estrazione di acidi nucleici da organi animali
DE2154279A1 (de) *	1970-11-03	1972-05-25	Crinos Industria Farmaco	Medikamente für das fibrinolytische System
IT1206341B (it)	1984-02-16	1989-04-14	Crinos Industria Farmaco	Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio.
US4694134A (en)	1985-05-28	1987-09-15	Ajax Magnethermic Corporation	Apparatus for overheating edges of skelp for the production of compression welded pipe
US5223609A (en) *	1986-04-17	1993-06-29	Crinos Industria Farmacobiologica S.P.A.	Process for obtaining chemically defined and reproducible polydeoxyribonucleotides
IT1190313B (it)	1986-04-17	1988-02-16	Crinos Industria Farmaco	Procedimento per l'ottenimento di polidesossiribonucleotidi chimicamente definiti e riproducibili e prodotto farmacologicamente attivo risultante
IT1223322B (it) *	1987-10-23	1990-09-19	Crinos Industria Farmaco	Metodo per prevenire la formazione di coaguli sanguigni nel circuito extracorporeo di apparecchi di dialisi a composizione utile per esso
JP2907447B2 (ja) *	1988-08-24	1999-06-21	中外製薬株式会社	抗血栓剤
IT1231509B (it) *	1989-09-07	1991-12-07	Crinos Industria Farmaco	Composizione farmceutica ad uso topico per la terapia della fragilita' capillare.
US5199942A (en) *	1991-06-07	1993-04-06	Immunex Corporation	Method for improving autologous transplantation
US5977083A (en) *	1991-08-21	1999-11-02	Burcoglu; Arsinur	Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states
JP3021906B2 (ja) *	1992-01-28	2000-03-15	松下電器産業株式会社	電動調理機
RU2136667C1 (ru) *	1995-04-18	1999-09-10	Научно-исследовательский институт фармакологии РАМН	Производные 2-меркаптобензимидазола, обладающие противоишемической, антиаритмической и противофибрилляторной активностью
JPH08127539A (ja) *	1994-10-31	1996-05-21	Ajinomoto Co Inc	ヒトｉｌ−１１を含有する末梢血幹細胞増加剤
CA2206496A1 (en) *	1994-11-30	1996-06-06	Chugai Seiyaku Kabushiki Kaisha	Thrombocytotic factor
WO1998001151A1 (en) *	1996-07-10	1998-01-15	Meiji Milk Products Co., Ltd.	Novel use of mk family as hematopoietic factor
WO1999026639A1 (en) *	1997-11-26	1999-06-03	Allegheny University Of The Health Sciences	Methods for mobilizing hematopoietic facilitating cells and hematopoietic stem cells into the peripheral blood
US6573372B2 (en) *	1999-01-07	2003-06-03	Heska Corporation	Feline immunoglobulin E molecules and compositions there of

2000
- 2000-04-18 EP EP00830293A patent/EP1147777A1/en not_active Withdrawn
2001
- 2001-04-10 US US10/432,741 patent/US20040131588A1/en not_active Abandoned
- 2001-04-10 RU RU2002130719/15A patent/RU2248216C2/ru not_active IP Right Cessation
- 2001-04-10 DK DK05108424.2T patent/DK1621207T3/da active
- 2001-04-10 IL IL152328A patent/IL152328A/en active IP Right Grant
- 2001-04-10 DK DK01931582T patent/DK1276497T3/da active
- 2001-04-10 AU AU5832201A patent/AU5832201A/xx active Pending
- 2001-04-10 EP EP05108424A patent/EP1621207B1/en not_active Expired - Lifetime
- 2001-04-10 AU AU2001258322A patent/AU2001258322B2/en not_active Ceased
- 2001-04-10 NZ NZ522016A patent/NZ522016A/en unknown
- 2001-04-10 SI SI200120022A patent/SI21079B/sl not_active IP Right Cessation
- 2001-04-10 ES ES05108424T patent/ES2335776T3/es not_active Expired - Lifetime
- 2001-04-10 CZ CZ20023426A patent/CZ20023426A3/cs unknown
- 2001-04-10 PT PT05108424T patent/PT1621207E/pt unknown
- 2001-04-10 JP JP2001576061A patent/JP5205668B2/ja not_active Expired - Fee Related
- 2001-04-10 RO ROA200201305A patent/RO121006B1/ro unknown
- 2001-04-10 DE DE60115222T patent/DE60115222T2/de not_active Expired - Lifetime
- 2001-04-10 HR HR20020835A patent/HRP20020835A2/xx not_active Application Discontinuation
- 2001-04-10 AT AT01931582T patent/ATE310532T1/de active
- 2001-04-10 AT AT05108424T patent/ATE443524T1/de active
- 2001-04-10 ES ES01931582T patent/ES2252227T3/es not_active Expired - Lifetime
- 2001-04-10 KR KR1020027013967A patent/KR100849491B1/ko not_active Expired - Fee Related
- 2001-04-10 EP EP01931582A patent/EP1276497B1/en not_active Expired - Lifetime
- 2001-04-10 PL PL01358100A patent/PL358100A1/xx not_active Application Discontinuation
- 2001-04-10 HU HU0300560A patent/HUP0300560A3/hu unknown
- 2001-04-10 WO PCT/EP2001/004105 patent/WO2001078761A2/en not_active Ceased
- 2001-04-10 MX MXPA02010346A patent/MXPA02010346A/es active IP Right Grant
- 2001-04-10 EE EEP200200596A patent/EE200200596A/xx unknown
- 2001-04-10 CA CA2406179A patent/CA2406179C/en not_active Expired - Fee Related
- 2001-04-10 DE DE60140015T patent/DE60140015D1/de not_active Expired - Lifetime
- 2001-04-10 CN CNB018082025A patent/CN1183962C/zh not_active Expired - Fee Related
- 2001-04-10 SK SK1489-2002A patent/SK14892002A3/sk unknown
- 2001-10-04 UA UA2002119177A patent/UA73566C2/uk unknown
2002
- 2002-10-14 IS IS6581A patent/IS2171B/is unknown
- 2002-10-16 NO NO20024988A patent/NO20024988L/no not_active Application Discontinuation
- 2002-10-17 BG BG107203A patent/BG107203A/bg unknown
- 2002-10-17 ZA ZA200208413A patent/ZA200208413B/en unknown
2006
- 2006-02-08 CY CY20061100179T patent/CY1104971T1/el unknown

Also Published As

Publication number	Publication date
WO2001078761A2 (en)	2001-10-25
EP1276497B1 (en)	2005-11-23
IL152328A (en)	2009-12-24
AU2001258322B2 (en)	2006-03-16
AU5832201A (en)	2001-10-30
EP1621207A2 (en)	2006-02-01
DK1621207T3 (da)	2010-02-01
PT1621207E (pt)	2009-12-28
CZ20023426A3 (cs)	2003-05-14
SI21079B (sl)	2006-08-31
UA73566C2 (en)	2005-08-15
ATE443524T1 (de)	2009-10-15
RO121006B1 (ro)	2006-11-30
NZ522016A (en)	2004-10-29
HRP20020835A2 (en)	2005-10-31
NO20024988D0 (no)	2002-10-16
CA2406179A1 (en)	2001-10-25
ZA200208413B (en)	2003-10-17
SI21079A (sl)	2003-06-30
KR100849491B1 (ko)	2008-07-31
HUP0300560A2 (hu)	2003-06-28
IS2171B (is)	2006-11-15
DE60115222T2 (de)	2006-08-10
EE200200596A (et)	2004-04-15
EP1147777A1 (en)	2001-10-24
RU2248216C2 (ru)	2005-03-20
ES2252227T3 (es)	2006-05-16
CN1183962C (zh)	2005-01-12
KR20030010603A (ko)	2003-02-05
PL358100A1 (en)	2004-08-09
CN1434719A (zh)	2003-08-06
SK14892002A3 (sk)	2003-06-03
RU2002130719A (ru)	2004-03-27
US20040131588A1 (en)	2004-07-08
ES2335776T3 (es)	2010-04-05
MXPA02010346A (es)	2004-09-06
JP5205668B2 (ja)	2013-06-05
EP1276497A2 (en)	2003-01-22
DE60115222D1 (de)	2005-12-29
BG107203A (bg)	2003-05-30
HUP0300560A3 (en)	2005-07-28
JP2004500437A (ja)	2004-01-08
IL152328A0 (en)	2003-05-29
ATE310532T1 (de)	2005-12-15
CY1104971T1 (el)	2010-03-03
DK1276497T3 (da)	2006-03-27
DE60140015D1 (de)	2009-11-05
NO20024988L (no)	2002-12-02
EP1621207A3 (en)	2006-11-22
CA2406179C (en)	2012-03-27
WO2001078761A3 (en)	2002-01-24
EP1621207B1 (en)	2009-09-23

Publication	Publication Date	Title
AU2001269688A1 (en)	2002-01-14	Combination containing an antifolate and methylmalonic acid lowering agent
IS6581A (is)	2002-10-14	Samsetning sem eykur hreyfanleika
GB9807639D0 (en)	1998-06-10	Anti-inflammatory agents
TW200505900A (en)	2005-02-16	Muscarinic agonists
DE69905368D1 (en)	2003-03-20	Oxydiertes thymosin beta 4
SE9702860D0 (sv)	1997-08-05	New use
MXPA03000188A (es)	2003-09-22	Metodo de tratamiento de enfermedades relacionadas con neutroficos con anestesicos locales.
MXPA02002681A (es)	2003-10-14	Uso de metabolitos de acido alfa-linolenico para el tratamiento o prevencion del cancer.
BG106057A (en)	2002-04-30	Method of enhancing the efficacy of anti-tumour agents
IL158155A0 (en)	2004-03-28	Use of erythropoietin to ameliorate chemotherapy-induced toxicity in vivo
WO2001089536A3 (en)	2002-08-01	Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
EP1542672A4 (en)	2006-06-07	R-BAMBUTEROL, ITS PREPARATION AND THERAPEUTIC USES
MY122838A (en)	2006-05-31	Treating allergic and inflammatory conditions
MD990258A (en)	2001-07-31	Method of treatment of the acute viral hepatitis B
NZ528164A (en)	2006-03-31	Use of flumazenil to produce a medicament for the treatment of cocaine dependency
EP1123100A4 (en)	2001-12-19	MEMORY IMPROVEMENT BY ADMINISTRATION OF DELTA-5-ANDROSTEN-3-BETA-OL-7,17-DION AND 3-BETA-ESTERS THEREOF
YU79802A (sh)	2005-11-28	Formulacija sa aktivnošću mobilizacije
ATE246479T1 (de)	2003-08-15	Absorbierender artikel mit kanal
DE69513632D1 (de)	2000-01-05	Mikrogranulate enthaltend 5-nitroimidazolderivate
MXPA04000418A (es)	2004-03-18	Tratamiento de dolor cronico con 3-heterocicloxi- y -cicloalquiloxi-3-fenilpropanaminas.
JPS51139004A (en)	1976-12-01	Rail with noise reducing constraction
MY136408A (en)	2008-09-30	Active substance combinations and therapies for treating abuse of alcohol
AU8716001A (en)	2002-02-18	Treatment of hepatitis c with thymosin and pegylated interferon